UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3091-3102

2001

Volltextzugriff (PDF)

PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2672-2679

2002

Volltextzugriff (PDF)

Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia

Blood, 1993-07, Vol.82 (2), p.343-362

1993

Volltextzugriff (PDF)

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

Journal of clinical oncology, 2003-01, Vol.21 (1), p.78-84

2003

Volltextzugriff (PDF)

Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma : A report from the IRSG

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.718-728

2001

Volltextzugriff (PDF)

Persistence of Circulating Blasts After 1 Week of Multiagent Chemotherapy Confers a Poor Prognosis in Childhood Acute Lymphoblastic Leukemia

Blood, 1995-08, Vol.86 (4), p.1292-1295

1995

Volltextzugriff (PDF)

Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil

Leukemia, 1997-05, Vol.11 (5), p.743-746

1997

Volltextzugriff (PDF)

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V

Journal of pediatric hematology/oncology, 2001-05, Vol.23 (4), p.215-220

2001

Volltextzugriff (PDF)

Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3487-3493

1999

Volltextzugriff (PDF)

What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?

Cancer, 2001-06, Vol.91 (12), p.2454-2468

2001

Volltextzugriff (PDF)

Benefit of Intensified Therapy for Patients With Local or Regional Embryonal Rhabdomyosarcoma: Results From the Intergroup Rhabdomyosarcoma Study IV

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2427-2434

2000

Volltextzugriff (PDF)

Biology and therapy of pediatric rhabdomyosarcoma

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2123-2139

1995

Volltextzugriff (PDF)

Indications for Radiotherapy and Chemotherapy After Complete Resection in Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Studies I to III

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3468-3475

1999

Volltextzugriff (PDF)

Treatment of Localized Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: Lessons Learned From Intergroup Rhabdomyosarcoma Studies III and IV

Journal of clinical oncology, 2003-02, Vol.21 (4), p.638-645

2003

Volltextzugriff (PDF)

Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Clinical cancer research, 2004-09, Vol.10 (18), p.6072-6079

2004

Volltextzugriff (PDF)

Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

European journal of cancer (1990), 2004-08, Vol.40 (12), p.1878-1885

2004

Volltextzugriff (PDF)

Biology and treatment of infant leukemias

Leukemia, 1995-05, Vol.9 (5), p.762-769

1995

Volltextzugriff (PDF)

Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital

The New England journal of medicine, 1993-10, Vol.329 (18), p.1289-1295

1993

Volltextzugriff (PDF)

Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age

Blood, 1996-04, Vol.87 (7), p.2870-2877

1996

Volltextzugriff (PDF)

Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

The New England journal of medicine, 1997-06, Vol.336 (25), p.1781-1787

1997

Volltextzugriff (PDF)

Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the intergroup rhabdomyosarcoma study IV (1991–1997)

Journal of pediatric surgery, 2000-02, Vol.35 (2), p.317-321

2000

Volltextzugriff (PDF)

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1150-1157

1997

Volltextzugriff (PDF)

Intergroup Rhabdomyosarcoma Study: update for pathologists

Pediatric and developmental pathology, 1998-11, Vol.1 (6), p.550-561

1998

Volltextzugriff (PDF)

Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma

Journal of pediatric surgery, 2000-02, Vol.35 (2), p.309-316

2000

Volltextzugriff (PDF)

Deregulation of a Homeobox Gene, HOX11, by the t(10;14) in T Cell Leukemia

Science (American Association for the Advancement of Science), 1991-07, Vol.253 (5015), p.79-82

1991

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(269)
Mit Volltextzugriff
(239)

Publikationsform

Artikel
(294)

Sprache

Englisch
(294)

Erscheinungsjahr

n.n

Thema

Humans
(234)
Science & Technology
(232)
Life Sciences & Biomedicine
(229)
Child
(187)
Biological And Medical Sciences
(152)
Medical Sciences
(147)
Child, Preschool
(133)
Male
(132)
Female
(125)
Oncology
(115)
Adolescent
(114)
Infant
(107)
Hematology
(96)
Hematologic And Hematopoietic Diseases
(82)
Prognosis
(72)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(67)
Pediatrics
(56)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(54)
Adult
(49)
Combined Modality Therapy
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

PAX3-FKHR and PAX7-FKHR Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma : A report from the IRSG

Persistence of Circulating Blasts After 1 Week of Multiagent Chemotherapy Confers a Poor Prognosis in Childhood Acute Lymphoblastic Leukemia

Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V

Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?

Benefit of Intensified Therapy for Patients With Local or Regional Embryonal Rhabdomyosarcoma: Results From the Intergroup Rhabdomyosarcoma Study IV

Biology and therapy of pediatric rhabdomyosarcoma

Indications for Radiotherapy and Chemotherapy After Complete Resection in Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Studies I to III

Treatment of Localized Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: Lessons Learned From Intergroup Rhabdomyosarcoma Studies III and IV

Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Biology and treatment of infant leukemias

Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital

Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age

Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the intergroup rhabdomyosarcoma study IV (1991–1997)

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance

Intergroup Rhabdomyosarcoma Study: update for pathologists

Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma

Deregulation of a Homeobox Gene, HOX11, by the t(10;14) in T Cell Leukemia

Suchergebnisse filtern